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PURPOSE. Diabetic retinopathy (DR) is a leading cause of vision impairment and blindness
worldwide in the working-age population, and the incidence is rising. Until now it has
been difficult to define initiating events and disease progression at the molecular level, as
available diabetic rodent models do not present the full spectrum of neural and vascular
pathologies.Zebrafish harboring a homozygous mutation in the pancreatic transcription
factor pdx1 were previously shown to display a diabetic phenotype from larval stages
through adulthood. In this study, pdx1 mutants were examined for retinal vascular and
neuronal pathology to demonstrate suitability of these fish for modeling DR.
METHODS. Vessel morphology was examined in pdx1 mutant and control fish expressing
the fli1a:EGFP transgene. We further characterized vascular and retinal phenotypes in
mutants and controls using immunohistochemistry, histology, and electron microscopy.
Retinal function was assessed using electroretinography.
RESULTS. Pdx1 mutants exhibit clear vascular phenotypes at 2 months of age, and disease
progression, including arterial vasculopenia, capillary tortuosity, and hypersprouting,
could be detected at stages extending over more than 1 year. Neural-retinal pathologies
are consistent with photoreceptor dysfunction and loss, but do not progress to blindness.
CONCLUSIONS. This study highlights pdx1 mutant zebrafish as a valuable complement to
rodent and other mammalian models of DR, in particular for research into the mechanistic
interplay of diabetes with vascular and neuroretinal disease.They are furthermore suited
for molecular studies to identify new targets for treatment of early as well as late DR.
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Diabetic retinopathy (DR) is a frequent late compli-cation of diabetes and a major cause of vision
loss in working-age individuals.1 Prominent microvascu-
lar changes, including reduced perfusion, disrupted vessel
integrity, and neovascularization, are accompanied by neural
retina dysfunction and cell degeneration.2 Initiating vascular
changes in DR involve reduced capillary blood flow, often
secondary to damage and loss of endothelial cells, as well
as microaneurysms.3,4 The consequence is insufficient reti-
nal oxygenation and an increased risk of plasma leakage
from affected vessels, which can lead to edema. These early
vascular changes constitute nonproliferative DR. Later stages
of disease, referred to as proliferative DR (PDR),5 are char-
acterized by neovascularization with associated vessel leak-
iness and scarring, which can progress to irreversible vision
loss.4
Although treatment with antiangiogenic agents often
limits disease progression and improves visual acuity in
patients with PDR, use of this therapeutic approach is
limited by the invasive intravitreal route of administration,
and by associated adverse effects, such as hypertension,
infection, and global vascular perturbation.6 Furthermore,
many patients are not responsive to antiangiogenics, or
become resistant over time.7 Laser photocoagulation is
also an option for slowing disease progression in PDR,
but this cannot reverse damage or provide a permanent
cure.
Neural-retinal damage, previously considered a
secondary effect of vessel insufficiency, is now increas-
ingly recognized as an early event and may in fact be a
direct consequence of hyperglycemia. Subsequent vessel
phenotypes may result from immune system activation
triggered by cell stress and photoreceptor apoptosis.5
Although pathological features have been well described,
the mechanistic link between hyperglycemia, and neural
retinal and vascular pathologies is not well understood.8
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There is a clear medical need to identify additional molec-
ular regulators of disease progression in DR to provide new
targets for therapeutic interventions. However, discoveries
have been limited by the lack of animal models that present
the full spectrum of pathological changes observed in the
vasculature and neural retina of DR patients.8 Rodent models
of hyperglycemia and diabetes, both chemically and geneti-
cally induced, typically recapitulate early vascular changes of
DR but do not develop later proliferative phases. Neuroreti-
nal changes, including photoreceptor degeneration and glial
activation, are a common finding in both type 1 and type 2
rodent models of diabetes.9 However, rodent retinal pheno-
types may not fully correlate with those of DR in humans,
as nocturnal rodents are generally cone-deficient animals,
whereas the human macula, responsible for visual acuity,
consists predominantly of cones. Furthermore, phenotype
and disease progression varies highly depending on the
model used, and molecular mechanisms underlying patho-
genesis and disease progression remain unclear.
The vertebrate model organism zebrafish is increasingly
used to model metabolic diseases and diabetes, provid-
ing advantages of small size, and ease of maintenance and
manipulation.10,11 Zebrafish can be rendered hyperglycemic
by incubation in a high glucose solution, which can be
maintained over several weeks.11 Ablation of beta cells also
leads to a temporary hyperglycemia, which resolves owing
to the regenerative capacity of beta cells in zebrafish.10 A
longer duration diabetic state is found in zebrafish that are
homozygous mutant for the pancreatic transcription factor
pdx1.12 The pdx1 mutant consistently shows decreased beta
cell number, reduced insulin, and hyperglycemia from larval
through adult stages. They are thus uniquely suitable among
zebrafish models for studying long-term effects of hyper-
glycemia.
In zebrafish, retinal structure and visual system physi-
ology closely resembles that of other vertebrates, includ-
ing mammals.13,14 Similar to humans, which depend on the
cone-rich macula for daytime vision, the zebrafish retina is
adapted for daylight vision and rich in cones.14,15 Hyper-
glycemic zebrafish, caused by high glucose incubation or
toxin-induced loss of beta cells, showed retinal thinning and
vasculature changes, as well as disruption of cone cells.16–18
However, there was no evidence for neovascularization,
perhaps due to limited duration of the treatments. Thus far
there have been no zebrafish models for PDR, or for earlier
stages of DR based on genetically induced diabetes.
Neovascularization has been seen in adult zebrafish
exposed to hypoxia,19,20 so wehypothesized that zebrafish
could show neovascularization under alternative pathologi-
cal conditions, such as the persistent hyperglycemia asso-
ciated with diabetes. In this study, we examined adult
pdx1 mutants for vascular and neuroretinal signs of DR
and followed progression with aging. To visualize reti-
nal vascular phenotypes,we generated zebrafish express-
ing the fli1a:EGFP endothelial cell reporter in the pdx1
mutant background. We report here that adult pdx1 mutant
fish develop multiple vascular phenotypes similar to those
observed in DR patients, including vasculopenia, vascular
leakage, and late-onset retinal neovascularization. Concur-
rently, there is variable loss of retinal neurons that shows
minimal progression over time. Overall, the diabetic pdx1
mutant zebrafish manifests vascular and neuroretinal pathol-
ogy seen in human DR, representing a promising model
to clarify disease mechanisms and identify new treatment
strategies.
METHODS
Zebrafish Maintenance
Zebrafish used were previously described pdx1 mutants,12
mixed males and females, maintained according to stan-
dard procedures as homozygous, heterozygous, and wild-
type siblings. Studies used nontransgenics and fish contain-
ing the fli1a:EGFP21 transgene. Animals were staged
by month as indicated or designated as young adult
(6–9 months) middle-aged (11–18 months), or aged
(>24 months). Genotyping was performed as previ-
ously described.12 All procedures were approved by the
Austrian Bundesministerium für Wissenchaft und Forschung
(GZ BMWFW-66.008/0009-WF/II/3b/2014, GZ BMWFW-
66.008/0004-WF/II/3b/2014, and GZ BMWFW-66.008/0018-
WF/V/3b/2017) and conducted in accordance with the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research.
Retinal Flat Mount Preparation and Imaging
Retinal or choriocapillary flat mounts were prepared as
previously described.22 In brief, zebrafish were euthanized,
and heads were fixed in 4% paraformaldehyde (PFA) at
4°C overnight. Retinae and choriocapillaries were isolated
from the other ocular tissues, cut radially 3 to 4 times,
and flat-mounted with the vitreal surface up on microscope
slides in VectaShield mounting medium (Vector Laborato-
ries, Inc., Burlingame, CA, USA). Vessels were visualized
using an LSM700 confocal microscope (Leica Microsystems,
Wetzlar, Germany). Several views were stitched together
when required for visualizing the entire vasculature.
For studies of vessel leakage, zebrafish were anes-
thetized in 0.02% buffered tricaine, weighed, and then
injected intraperitoneally with 2 to 4 μL lysine-conjugated,
rhodamine-labeled dextran (70 kDa, 6.25 mg/mL) diluted in
phosphate-buffered saline (PBS). After recovery in normal
fish water, dextran circulated for 90 minutes before the fish
were euthanized.
Vessel Quantification and Statistical Analysis
Arterial density was quantitated in Photoshop (Adobe, San
Jose, CA, USA) by calculating the vessel signal area (green
pixels) divided by the total pixel area in eight areas from
four individual fish per group. Vessel diameter was measured
using ImageJ software (National Institutes of Health,
Bethesda, MD, USA) in 15 vessels from 4 individual fish per
group. Sprouts and branches were counted in 10 regions
from 3 individual fish per group. Areas analyzed included
dorsal, ventral, temporal, and nasal regions. Glucose
transporter-1 (Glut1; Merck Millipore, Darmstadt, Germany)
and zonula occludens 1 (ZO.1; Invitrogen, Carlsbad, CA,
USA) staining was quantified (using Photoshop) by deter-
mining the percentage of signal overlap between regions
positive for the EGFP+ endothelium and the antibody label.
Transgelin1-labeled arterial vessels were outlined based on
identification of weakly autofluorescent erythrocytes in the
vascular lumens. Vessel perfusion was quantified (using
Photoshop) by calculating the luminal dextran signal area
(yellow pixels as dextran were recorded in the red chan-
nel and the vessels in the green channel) divided by the
total vessel area (green pixels in the green channel). Leak-
age was quantified as the extra vascular dextran signal area
(i.e., red pixels in dual-color overlays) divided by the total
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dextran signal area (i.e., red + yellow pixels in dual-color
overlays).
Data were found to be normally distributed and
differences between two groups were evaluated using
heteroscedastic t-tests using Welch-correction for unequal
variance, whereas multigroup comparisons were done using
ANOVA with Tukey’s post hoc test when comparing individ-
ual groups with equal variance. P values are indicated in the
figures using the following symbols: *P < 0.05, **P < 0.01,
and ***P < 0.001.
Immunohistochemistry
For flat mounts, fixed eyes from adult zebrafish were washed
3 times with PBS and further incubated in PBS for 2 hours
at room temperature or 24 hours at 4°C. Retinal or choroid
tissues were isolated by careful dissection and incubated in
proteinase K (20 μg/mL) for 5 minutes at room tempera-
ture on a rocking table. Tissues were then incubated for
30 minutes at room temperature in absolute methanol,
followed by 0.3% Triton X-100 (Karl Roth, Karlsruhe,
Germany) in PBS (PBS-Tx) for 30 minutes at room temper-
ature with rocking, followed by blocking in 3% milk in
PBS-Tx overnight (16–24 hours) at 4°C. After washing three
times in PBS-Tx, tissues were incubated in primary anti-
bodies recognizing Glut-1 (4 μg/mL), ZO.1 (4 μg/mL), or
transgelin123 (1:200 dilution) diluted in 0.3% PBS-Tx for
24 hours at 4°C. Tissues were then washed three times
in PBS-Tx, incubated in PBS-Tx for 90 minutes at 4°C,
reblocked in 3% milk PBS-Tx for 90 minutes at room temper-
ature, and incubated with a secondary antibody, Alexa fluor
555, goat anti-rabbit (Life Technologies, Carlsbad, CA, USA)
at a concentration of 10 μg/mL in blocking buffer, overnight
at 4°C. Tissues were washed three times in PBS-Tx and then
mounted within viewing chambers in VectaShield (Vector
Laboratories).
Immunohistochemistry on frozen sections was
performed essentially as described24 with the following
modifications. Isolated eyes were fixed for 2 hours at room
temperature in 4% PFA, followed by incubation in 30%
sucrose prior to sectioning in optimal cutting temperature
embedding medium (OCT). Primary antibodies (mouse anti-
Zpr1, Zebrafish International Resource Center, Eugene, OR,
USA; mouse anti-glutamine synthetase, MAB302, Chemicon
International, Temecula, CA, USA) were diluted 1:400 in
blocking solution and incubated overnight. The secondary
antibody (Invitrogen) was diluted 1:1000 in PBS and incu-
bated for 1 hour. BODIPY TR Methyl Ester (Invitrogen) was
diluted 1:300 in PBS and stained for 20 minutes. Nuclei were
counterstained with DAPI 1:1000 in water for 3 minutes.
Fluorescence intensity of glutamine synthetase (GS) was
measured in single z-slices using ImageJ software over
regions spanning the inner nuclear layer (INL) to the outer
limiting membrane (OLM). Cone photoreceptor length
was estimated using ImageJ software (https:// fiji.sc/ ).25
Ultraviolet (UV) cones were identified based on position
and pattern of BODIPY staining of photoreceptor outer
segments.24,26 UV cone length (outer and inner segment
length) was measured in 78 control cells, 73 cells from
mutant with mild electroretinogram (ERG) phenotype, and
58 with severe phenotype. Double cone length (synapse to
distal edge of inner segment) was measured in 170 control
cells, 103 cells from mutants with mild ERG phenotype, and
209 with severe phenotype. Graphs were prepared in Prism
(GraphPad, San Diego, CA, USA).
Histology and Electron Microscopy
For histology and transmission electron microscopy, whole
eyes were fixed in a mixture of 4% PFA/2.5% glutaralde-
hyde diluted in 0.1M Na cacodylate (pH = 7.4) at room
temperature (RT) for 3 hours followed by overnight at 4°C.
Retinas were rinsed in 0.1M Na cacodylate, then incubated
in 0.1M Na cacodylate containing 6% sucrose. Specimens
were washed with 0.1M Na cacodylate buffer and post-
fixed in 2% osmium tetroxide buffered in 0.1M Na cacody-
late at 4°C. After 1 hour, specimens were washed two
times with 0.1M Na cacodylate buffer and three times with
distilled water. Staining with 1% aqueous uranyl acetate was
performed en block at 4°C for 1 hour. Specimens were then
washed three times with distilled water and dehydrated in
a series of ascending concentration of ethanol and propy-
lene oxide. Infiltration took place in three steps, and finally
the samples were embedded in Araldite 502/Embed 812
(Electron Microscopy Science, Hatfield, PA, USA) embed-
ding media at 60°C for 24 hours (according to the manufac-
turer’s protocol). Blocks were trimmed and sectioned using
a REICHERT ULTRACUT S ultramicrotome (Leica Microsys-
tems). Semithin sections (1 μm thickness) were stained with
1% toluidine blue in 1% boric acid. Ultrathin sections (70
nm thickness) were collected onto formvar-coated slot grids
and counterstained with uranyl acetate and lead citrate. The
observation and examination of the sections was performed
on a 100kV Jeol JEM1230 (JEOL, Peabody, MA, USA) trans-
mission electron microscope.
Feulgen staining was performed essentially as
described.27 In brief, eyes were fixed overnight in 4%
PFA, dehydrated in an increasing ethanol series, and
embedded in Technovit 7100 (Kulzer GmbH, Wehrheim,
Germany) according the manufacturer’s protocol. Then
3 μm sections were cut with an Autocut 2040 (Reichert,
Vienna, Austria), collected on glass slides, and stained by the
Feulgen reaction. Slides were examined with a DM5000B
microscope (Leica Microsystems) and imaged with a DF490
digital camera using the Leica application suite version 4.8
(Leica Microsystems). Cell types were determined based on
position along the apical-to-basal axis and morphology27,28
(apical is toward the retinal pigment epithelium [RPE]). Rod
nuclei in the outer nuclear layer (ONL) were distinguished
based on their densely stained nuclei, whereas UV cone
nuclei were larger, paler, and located basal to the OLM.
Elongated red, green, and blue (RGB) cone nuclei are
located apical to the OLM.
Electroretinograms
ERGs were performed essentially as described.29 Prerecord-
ing preparations were performed under dim red right. Fish
were dark-adapted for at least 30 minutes, then anesthetized
with tricaine (MESAB; Merck, Darmstadt, Germany). Isolated
eyes were positioned on an agarose-filled chamber facing
the light source. The recording electrode was filled with
E3 (5 mM NaCl; 0.17 mM KCl; 0.33 mM MgSO4; 0.33 mM
CaCl2; pH 7.5 in ddH2O) and placed against the center
of the cornea, the reference electrode was inserted into
the agarose. A stimulus of 100 ms was applied 50 ms
after start of tracing. Response to stimulus was recorded
three times per sample. Traces were normalized to the
baseline, defined by the average potential before the stim-
ulus. The b-wave amplitude was calculated from the trough
of the a-wave to the peak of the b-wave.30 Results were
Downloaded from iovs.arvojournals.org on 02/28/2020
Pdx1 Mutant Zebrafish Develop Diabetic Retinopathy IOVS | February 2020 | Vol. 61 | No. 2 | Article 43 | 4
FIGURE 1. Adult pdx1 mutants show vascular changes consistent with DR. (A) Retina flat mounts from middle-aged (18 months old)
fli1a:EGFP transgenics, wild type (left) or pdx1−/− (center), and a close-up view of a wild type (right), with regions of the vascular plexus
indicated. Arteries originating from the ophthalmic artery progressively branch to form a peripheral capillary plexus that drains into the
circumferential vein (C. vein). Size bar indicates 500 μm. (B) Images of retinal vasculature in flat-mounted retinae from middle-aged adult (14–
18 month old) pdx1+/+; fli1a:EGFP controls and pdx1−/−; fli1a:EGFP mutants focusing on central arteries (top) and peripheral capillaries
(bottom). In mutants, arteries show narrowing, whereas capillaries have increased sprouts and branches. Size bars indicate 50 μm. (C)
Quantitation of vessel diameter in 15 arteries from 4 individual fish per group, and (D) sprouting in 10 capillary regions from 3 individual
fish per group, from samples as shown in B. ***P < 0.001.
analyzed using Excel (Microsoft Corp., Redmond, WA, USA),
and graphs were prepared in Prism (GraphPad). Smoothing
was applied to plotted response curves.
RESULTS
Progressive Retinal Vascular Changes Caused
by Persistent Hyperglycemia
Pdx1 mutant zebrafish are a vertebrate genetic model that
stably displays key features of human diabetes.12 Impor-
tantly, homozygous mutants survive to adulthood, thus
providing a consistent disease-affected population in which
to identify DR phenotypes that progress over time. As DR
is clinically characterized in large part based on vascular
lesions,31 we investigated the retinal vasculature in pdx1
mutants to determine the presence and extent of DR-
associated lesions.
The adult zebrafish retina shows a highly organized
vascular pattern13,19 (Fig. 1A). The retinal vasculature initi-
ates as the ophthalmic artery that pierces the retina and
forms a variable number of main artery branches (4–9),
which arborize as progressively narrower vessels before
forming a capillary plexus. This plexus connects with venous
capillaries at the periphery, which drain into the circumfer-
ential vein (Fig. 1A).
Vessel morphology was observed in flat mounts of
retinae from middle-aged adult (15–18 month) diabetic
pdx1 mutants and age- and genetic background-matched
controls expressing the fli1a:EGFP transgene. Although
global patterning of vessels appeared normal (Fig. 1A),
features consistent with DR were detected on closer inspec-
tion of the arterial and capillary regions throughout the
360 degrees of the flat-mounted sample. Vessel constriction
and points of stenosis were observed in the central arter-
ies (Figs. 1B, top, 1C). Average vessel diameter was reduced
seven-fold in pdx1 mutants. In comparison to controls, reti-
nal capillaries of mutants at this stage showed tortuosity with
increased vessel density, sprouting and branching (Fig. 1B,
bottom). Sprouts were observed along the length of the
capillaries, which in some cases connected with nearby
vessels creating a branch (Figs. 1B, bottom, 1D).
Additional vascular lesions were noted in capillar-
ies, as well as arteries, which suggested that cellular
integrity was compromised. Specifically, hyperfluorescent
and hypofluorescent perivascular deposits were detected
adjacent to fli1a:EGFP-expressing vessels, suggesting that
these contained endothelium-derived EGFP (Supplemen-
tary Fig. S1). We hypothesize that these structures, which
were not observed in the hypoxia-induced retinopathy
model,19,20 could be signs of vascular damage. In zebrafish
as in mammals, a specialized choroidal vasculature overlies
the RPE. This vessel network, characterized by a sheath-
like morphology, appeared unchanged in pdx1 mutants as
compared with controls (Supplementary Fig. S2).
The hypoxia and VEGF upregulation that are character-
istic of DR have been proposed to be a consequence of
decreased arterial perfusion, which then triggers capillary
sprouting.32 To determine the sequence of vascular lesion
development in our model, we analyzed retinal vessels at
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FIGURE 2. Vascular phenotypes progress over time. Retina flat mounts of pdx1−/− mutants and pdx1+/+ controls, transgenic for fli1a:EGFP,
showing representative areas of arteries (A) and capillaries (D) at the ages indicated, from 2 months through 15 months of age. Size bars
indicate 50 μm. (B, C) Quantitation of arterial diameter (B) and density (C) in 15 vessels or 15 regions respectively from 4 individual fish
per group, from samples as shown in A. m, months, ns, not significant. ***P < 0.001. (E, F) Quantitation of the number of capillary sprouts
(E) and branches (F) in 10 capillary regions from 3 individual fish per group, from samples as shown in D. p, pdx1, m, months. **P < 0.01,
***P < 0.001.
2, 3, 6, 9, and 15 months in mutants and controls. Signifi-
cant arterial narrowing and decreased arterial density was
detected at 6 months, which progressed in severity at 9 and
15 months (Figs. 2A–C). The capillary phenotype was appar-
ent at earlier stages, with increased sprouts and branching
detected already at 2 months. This abnormal vessel growth
increased in severity with time, with bursts of increased
sprouting observed at 6, 9, and 15 months, correlating with
involvement of arterial constriction. At 15 months, the capil-
laries had developed clear neovascular features (Figs. 2D–F).
Downloaded from iovs.arvojournals.org on 02/28/2020
Pdx1 Mutant Zebrafish Develop Diabetic Retinopathy IOVS | February 2020 | Vol. 61 | No. 2 | Article 43 | 6
Overall, these data suggest that early capillary changes may
occur prior to, but are likely aggravated by, arterial constric-
tion.
Molecular Defects in the Vasculature Reflect
Disruption of Blood–Retinal Barrier
An intact barrier between the retinal vasculature and
parenchyma (blood–retinal barrier [BRB]), formed by
endothelial cells, glial cells, and mural cells, maintains tight
regulation of nutrient transport, and is essential for retinal
integrity and function.33 Leaky vessels, which permit influx
of signaling mediators and inflammatory cells, are character-
istic of DR as endothelial cells become dysfunctional under
conditions of metabolic stress.5,34 BRB permeability is regu-
lated through intercellular tight junctions, which contain
proteins such as the cytoplasmic adaptor ZO.1.33 To define
early and progressive changes in BRB integrity in pdx1
mutants, we examined expression of ZO.1 at 3 and 9 months
using immunohistochemistry staining. At 3 months, ZO.1
expression was not yet prominent (Figs. 3A, 3C). The
9 month old controls showed strong ZO.1 expression in
perivascular cells and weaker expression in endothelial cells
within the capillary network (Fig. 3B, top). By contrast, ZO.1
expression in mutants was strongly reduced at 9 months as
compared with controls (Figs. 3B, 3D).
Glut1 is responsible for transport of glucose from the
vasculature into the retinal tissue, and is a marker of a
mature and healthy BRB.35 Changes in retinal Glut1 expres-
sion have been reported in DR patients and mouse models,
but mechanisms and physiological consequences of this
regulation are unclear.36 As detected by immunohistochem-
istry in a flat-mount preparation, Glut1 was expressed in reti-
nal vessels in all regions visualized, particularly in the capil-
laries (Supplementary Fig. S3). Glut1 expression observed
in retinal capillaries of wild types at 3 and 9 months was
largely absent in mutants at these stages (Figs. 3E–H).
Loss of pericytes is an early feature of the vascular pathol-
ogy in DR and contributes to disruption of the BRB by subse-
quently increasing vascular permeability.37 Arterial blood
vessels are tightly covered by a layer of vascular mural
cells (smooth muscle cells and pericytes), which contributes
a supportive scaffold and provides regulatory functions.23
Transgelin1, an actin cross-linking protein, is an early marker
of mural cells.23 At 3 months, transgelin1 expression in
mural cells was evident in primary branches of the optic
artery in controls but not in mutants (Fig. 3I). At 9 months,
both primary and secondary arterial branches were covered
with transgelin1-positive mural cells in controls, whereas
only primary branches were associated with such cells in
the mutants (Fig. 3J). In middle-aged controls (18 months),
tertiary arteriolar branches were enriched in transgelin1-
positive mural cells, whereas only primary arterial branches
of the optic artery were covered by these cells in the mutants
(Supplementary Fig. S4).
Vessel leakiness may be a consequence of patholog-
ical disruption of the BRB, but is also characteristic of
newly formed vessels.4 To directly demonstrate vessel leak-
age, retinae were harvested from 6-month-old fli1a:EGFP
transgenic fish 90 minutes following intraperitoneal injec-
tion of low molecular weight (70kD) rhodamine dextran
(Rho-Dex). Examination of vessels in flat mounts revealed
extravascular exudates in pdx1 mutants, that were absent
in control samples (Figs. 4A, 4C). These exudates were
found adjacent to established vessels, as well as in regions
of neovascular branches and sprouts. This suggests leak-
age from both breakdown of previously functional barriers
and from insufficient barrier formation in newly sprouting
vessels. We also quantitated the degree to which the injected
Rho-Dex filled the capillary vascular space, defined by
fli1a:EGFP transgene expression, as an indication of vascu-
lar perfusion. This analysis revealed significantly reduced
vessel perfusion in mutants as compared with controls
(Fig. 4B).
To define early changes at the ultrastructural level, we
examined retinal vessels at 6 months using transmission
electron microscopy (TEM). Retinal arteries in wild types
were as expected: thin-walled, exhibited highly condensed
tight junctions, and established close contacts with vascu-
lar mural cells (Fig. 4D, left). In mutant fish, however, the
endothelium was dramatically thickened and swollen, likely
causing the observed luminal constriction and hypoper-
fusion observed from 6 months onward (Fig. 4D, right).
Furthermore, tight junctions appeared less dense, with wider
interendothelial space within the junctions compared with
age-matched controls. Mural cell coverage was less tight and
fluid-filled spaces were frequently found between endothe-
lial and vascular mural cells of the mutant fish (Fig. 4D,
right).
In the capillary region, control fish exhibited relatively
thin endothelia, albeit with a few vesicles likely impor-
tant for transport across the BRB (Fig. 4E). The base-
ment membrane was condensed and continuous in this
region. In the mutants, however, the endothelium was thick-
ened and contained many more vesicles, including several
macropinosomes that were not observed in control fish,
suggesting elevated transendothelial transport and leakage
of fluid. The basement membrane was much less condensed
and appeared discontinuous and partly degraded (Fig. 4E).
Overall, these findings are consistent with disruption of the
BRB, with increased vessel permeability and leakiness, in
the retina of pdx1 mutants.
Neural-Retina Changes in pdx1 Mutants Affect
Photoreceptors and Müller Glial Cells
Pathological changes in retinal vessels, visualized by
ophthalmoscope examination, have historically been the
major criteria for assessing DR in patients.2,38 However,
vessel alterations are often accompanied by alterations
in retinal neurons that are more challenging to detect.38
The zebrafish retina, comparable to all vertebrates includ-
ing mammals, contains three nuclear and two synaptic
layers. Neuronal cell bodies are found in nuclear layers,
whereas axonal and dendritic processes extend and make
connections within the intervening plexiform layers. The
INL contains the cell bodies of neural bipolar, horizon-
tal, and amacrine cells, as well as the Müller glial cells.
Photoreceptors reside in the ONL and adjacent photorecep-
tor layer, their light-collecting outer segments are supported
by processes from the underlying RPE (Fig. 5A).
Histological examination of retinal sections from middle-
aged controls and pdx1 mutants (12 months old) revealed
differences in the outer and inner nuclear layers (Figs. 5A).
Mutants showed increased nuclei in the INL and decreased
nuclei in the ONL (Figs. 5A, 5B, 5D). Closer analysis of
photoreceptors, distinguished based on nuclear morphol-
ogy and location,28,39 revealed that rods and RGB cones
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FIGURE 4. (A) Retinal flat mounts from 6-month-old pdx1 mutants and controls, transgenic for fli1a:EGFP and previously injected with
rhodamine-labeled dextran (Rho-Dex, red). Areas of poor Rho-Dex perfusion through the vessels (yellow arrowheads) and areas of Rho-Dex
leakage (white arrows) are clearly evident in pdx1 mutants but not in controls. Size bars indicate 50 μm. (B, C) Quantification of perfusion
(B) and leakage (C) in the retinal capillaries in 10 regions of 3 individual fish per group from samples as shown in A. ***P < 0.001. (D, E)
TEM images of retinal sections from 6-month-old pdx1mutants and controls focusing on arterial (D) or capillary (E) vessels, showing swollen
endothelium, loosened contacts between endothelial cells (EC), and mural cells (MC, red arrowheads), and partially dissolved, loosened tight
junctions (TJ, blue arrowheads) in the arteries of mutants compared with controls (D). Also shown is an increased number of vesicles (red
arrows), and disrupted basement membrane (BM) in the capillaries of mutants compared with controls (E). Black boxes in the overview
images (upper rows) indicate the areas magnified in the images below (lower rows). Size bars in overview and magnified images indicate
5 μm and 100 nm, respectively.
were significantly reduced (Figs. 5E, 5G), whereas UV
cone numbers were essentially unchanged in mutants as
compared with controls (Fig. 5F). Cell numbers in the
ganglion cell layer, which contains the output neurons
of the retina, were comparable in mutants and controls
(Fig. 5C). We additionally analyzed retinae from young
(6 month) and middle-aged (15–16 months) adults by TEM.
Changes in ONL and INL were already present in young
adult samples (Fig. 5H). Middle-aged adults additionally
demonstrated pyknotic nuclei in the ONL, and shortened
cone outer segments (Fig. 5I).
Müller glial cells of the retina reinforce retinal archi-
tecture and help maintain metabolic homeostasis of reti-
nal neurons.40 To aid in this supportive role, processes of
Müller glia cells extend laterally within the retina, and span
radially to reach the outer limiting membrane.41 Follow-
ing injury in the retina, Müller glial cells become activated
and show hypertrophy in a process referred to as reac-
tive gliosis.41,42 To examine the status of Müller glial cells
in pdx1 mutants, we performed antibody staining for the
specific marker GS. Hypertrophic changes were observed
starting from young adult stages, with enhanced expression
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FIGURE 5. Pathology in the neural-retina of pdx1−/− mutants. Toluidine blue (A) and Feulgen (B) staining in sections of the outer retina
from middle-aged (12 month) pdx1 mutant or control zebrafish. Based on Feulgen histology, rod photoreceptor nuclei in the ONL are
densely stained (B, top, black arrows), whereas UV cone nuclei located apically within the ONL are larger and lighter stained (B, top, blue
arrowheads). Elongated nuclei of RGB cones are found apical to the OLM (B, top, black arrowhead). Size bar indicates 50 μm (A) or 10 μm
(B). (ILM, inner limiting membrane; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer;
ONL, outer nuclear layer; PL, photoreceptor layer; RPE, retinal pigment epithelium; OLM, outer limiting membrane). C-G Quantification of
indicated cell types (for details, see Methods section) in 10 or more regions of 50 μm width from 3 individual fish per group (from samples
as shown in A, B). **P < 0.001, ***P < 0.0001, ns, not significant. (H, I) TEM images of the outer retina from 6-month-old young (H)
or middle-aged adult (14–16 months) (I) controls and pdx1 mutants. Similar to middle-aged samples, young adult mutants show reduced
ONL (H, left). Rod (r) and cone (c) outer segments can be identified. In middle-aged adults, cone outer segments (I, white arrowheads)
appear shortened in mutants as compared with controls. In addition, pyknotic nuclei (blue arrowheads) are present in the ONL of pdx1
mutants (I, bottom) (c, cone, r, rod). Size bars indicate 25 μm (H, right), 5 μm (H, left), or 10 μm (I). (J) Cryosections of controls (left)
and pdx1−/− mutants (right) at young adult (7 months) and middle age (17 months), immunostained with anti-glutamine synthetase (GS,
magenta). Pdx1−/− mutants show enhanced signal in the outer retina, and hypertrophic processes at the OLM (arrow). (pdx1+/+, n = 4;
pdx1−/−, n = 6). Size bar indicates 20 μm.
of GS (Fig. 5J, Supplementary Fig. S5). Specifically, we could
clearly observe Müller cell processes encircling nuclei in the
ONL (Fig. 5J, Supplementary Fig. S5A), as has been previ-
ously described following photolesion damage to zebrafish
retina.42 These changes were observed at stages spanning
young adult to middle age, suggesting persistent activation.
Photoreceptor Deficiencies Correlate with
Dysfunction of the Outer Retina
We next determined whether the changes in the neural
retina in pdx1 mutants caused corresponding defects in
retinal function. An ERG, which detects light-induced
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field potential change in the whole retina, can be used
to analyze outer retinal function.43 We measured ERG
responses to bright light stimuli in dark-adapted middle-
aged (11 months old) adults, which provides a larger ampli-
tude response compared with light-adapted testing, and
interrogates function of both rods and cones.44 Specifi-
cally, the b-wave amplitude represents the depolarization
of on-bipolar cells induced by the hyperpolarization of
photoreceptors. Reduced b-wave amplitude reflects disrup-
tion of synaptic transmission downstream of photorecep-
tors. Consistent with perturbation of photoreceptor func-
tion, average b-wave amplitude was reduced in the mutants
(Fig. 6A, **P < 0.01).
To correlate ERG responses with the status of photore-
ceptors, we labeled retinal sections with BODIPY to high-
light lipid membranes, and Zpr1 antibody to label red-
green double cones.45 We examined retinae from controls,
mutants that showed mild or no defect in ERG response
(mild), and mutants that showed a strong b-wave reduc-
tion phenotype (strong, Fig. 6B). In controls, double cones
have an elongated columnar morphology revealed by Zpr1
antibody staining (Fig. 6C). Zpr1 staining in retinae from
mutants with mild ERG phenotype appeared less regu-
lar and cones showed significant shortening (Figs. 6C, 6D,
top). In mutants with strongly reduced b-wave amplitude,
these cones had a rounded shape and the length was
further decreased. Based on their cell body location in the
ONL, BODIPY-labeled UV cone morphology can be quan-
titated.24,26 Although by histology we found the number
of UV cones to be unchanged (Fig. 5F), BODIPY labeling
revealed disorganized and shortened UV cones in mutants,
with the severity correlating with reduced ERG response
(Figs. 6C, 6D, bottom). Overall, this analysis shows that
photoreceptors were impacted at both the morphologic and
functional level.
As DR leads to blindness in human patients, we
examined whether visual deficits increased in severity
during the aging of the mutants. Although pdx1 mutants
show decreased viability as adults,12 rare mutants survive
into later adulthood. In aged adults (>24 months post-
fertilization), ERGs of mutants showed b-wave ampli-
tudes that were significantly reduced compared with
controls (Fig. 6E, *P < 0.05, 6F). However, they were
not completely lacking in response. Interestingly, the
mean ERG response in mutants between middle-aged (b-
wave amplitude = 0.63 ± 0.44 mV) and aged adult
(b-wave amplitude = 0.58 ± 0.31 mV) was similar
(P = 0.99, unpaired t-test). To determine changes in overall
cone status over time, we quantified cone numbers based
on DAPI staining of the outer segments.46 In young adult,
as well as in aged adults, comparing mutant to age- and
background-matched controls, a significant decrease in cone
photoreceptor number was detected (Figs. 6G–H). Thus
although there was a detectable and significant defect in reti-
nal function and a correlating pathology in photoreceptors,
it was not more severe in mutants that survived for more
than 2 years.
DISCUSSION
We describe here the pdx1 mutant zebrafish12 as a new
and clinically relevant model for DR. In contrast to previous
models limited to short duration treatments and assessing
phenotypes at a single time point, we report a DR model
amenable to being assessed at early as well as later time
points. We observed progressive retinal vascular pathologies
affecting both arteries and capillaries, as well as degenera-
tive changes in photoreceptors.
Recent mouse DR models feature multiple genetic alter-
ations, or take advantage of variation in background genetic
susceptibilities, in attempts to better represent human
disease. However, these models often do not represent
genetic modifications associated with human disease,47 or
are so severely hyperglycemic as to only permit development
of early pathologies.48 In addition to type 1 diabetes models,
manipulations of rodents that recapitulate the metabolic
disturbances of type 2 diabetes show evidence of retinal
neurologic and vascular disruptions,9,49 but manifest mainly
the early stages of disease development as seen in humans.
The pdx1 mutant zebrafish most resembles human
neonatal diabetes, as the early onset diabetic state occurs
only in homozygous mutants and is associated with exocrine
pancreas developmental defects.12,50 Pdx1 mutations are
a rare cause of diabetes in the human population, with
clinical manifestations that vary depending on the precise
genetic lesion. Although our model is based on a rare condi-
tion in humans, it is valuable in creating a β-cell defi-
cient and hyperglycemic state that recapitulates the persis-
tent metabolic dysregulation of human diabetes. Severity
of human DR, independent of diabetes etiology, is fore-
most associated with duration of diabetes and degree of
hyperglycemia.4 Future studies in the pdx1 mutant zebrafish
model can explore how gender, additional genetic loci, and
environmental factors such as diet, modify DR onset and
progression.
In contrast to glucose-induced DR in zebrafish, in which
cones were found to be more susceptible to disruption,16 our
model shows perturbation affecting both rods and cones.
Several factors could account for this difference, in partic-
ular the nature of the initiating treatment and the persis-
tence of disease state. Zebrafish diabetes models of limited
duration16,51 may elicit modest downstream pathologies as
compared with effects seen with sustained genetic disrup-
tion of glucose homeostasis, as in the pdx1 mutant.
In rodent DR studies, there is loss of photoreceptors
and degeneration of photoreceptor outer segments, variably
impacting rods and/or cones, depending on the diabetes
model.52 Photoreceptor changes in diabetic patients have
not yet been widely assessed, but several studies have
shown pathologic effects.52 Candidate factors for mediat-
ing tissue damage in DR include reactive oxygen species
(ROS), hypoxia, and immune system activation, although
the precise molecular sequence of events remains unclear.34
Photoreceptors are the most metabolically active cells in the
retina, with the consequence of high mitochondrial activ-
ity and increased ROS generation.53 Rod and cone outer
segments, cellular compartments with minimal antioxidant
activity, undergo continuous removal and renewal to replace
damaged cellular components and maintain high visual func-
tion.54 One hypothesis is that, in retinal disease states, insuf-
ficient renewal of damaged outer segments compromises
photoreceptor viability.54
Vascular development and vascular growth in response
to hypoxia are well studied, and zebrafish has been a fruit-
ful model in these investigations.20 Although inappropriate
new vessel formation (neovascularization) leads to devas-
tating vision loss in DR, the initiating lesions are charac-
terized by vessel drop-out.55 Because of a lack of good
models to study these first events, few molecular play-
ers have been identified, resulting in limited therapeutic
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FIGURE 6. Retinal functional defects and photoreceptor loss are detected in pdx1−/− mutants. (A) b-wave amplitude of wild type and pdx1−/−
mutants middle-aged adults (11 months old), as measured by ERG (A, pdx1+/+, n = 11; pdx1−/−, n = 8, **P < 0.01, unpaired t-test). (B) ERG
recordings from representative controls, mutants with no to mild defect in response (mild) and with strong b-wave reduction phenotype
(strong). (C) Cryosections labeled with anti-Zpr1 (top, magenta) and BODIPY (bottom, magenta), with nuclei counterstained by DAPI (blue),
from samples with ERG tracings as shown in B (control, n = 2; mild, n = 2; strong, n = 2). Size bars indicate 10 μm. (D) Quantitation of
length of double cones (top) and UV cones (bottom), measured from images as shown in (C). (Details of quantitation are described in the
Methods section.) (E) b-wave amplitudes from ERG recordings of aged adults (pdx1+/+, n = 5; pdx1−/−, n = 7, *P < 0.05, unpaired t-test).
(F) Electroretinogram recordings from representative aged adult (>24 months old) pdx1+/+ control (green) and pdx1−/− mutant (orange).
(G, H) Sections of the outer nuclear layer and photoreceptors from young (G) or aged adult (H) pdx1 mutants or controls stained with DAPI
(gray). Graph indicates quantification of the number of hyperfluorescent cones in 5 regions of 50 μm in width from 3 individual young adult
(7 months) (G) or aged adult (>24 months) (H) samples as shown. *P < 0.05, ***P < 0.001, unpaired t-test. Size bar indicates 20 μm.
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options to counteract vessel loss in early DR. The zebrafish
DR model we report here demonstrated characteristic early
vascular changes, including pericyte loss, BRB breakdown,
and decreased perfusion, and further investigations will aim
to discover responsible signaling pathways.
Pdx1 diabetic mutants showed consistently progressing
vascular changes that at later stages highly correlated with
human PDR. By contrast, we did not see relentless progres-
sion in the retinal neuron phenotype. We did observe persis-
tent upregulation of GS, a Müller glial protein that serves
as a potent neuroprotectant.56 This response could serve
to promote photoreceptor survival in the face of toxic
metabolic injury, and help to maintain visual function, even
with advanced age. Future studies will address whether,
in our metabolic retinopathy model, Müller glial activa-
tion serves primarily a neuroprotective function, or whether
there is an accompanying regenerative response, as seen in
other zebrafish retinal injury models.41
CONCLUSIONS
Overall, this study demonstrates that pdx1 mutant zebrafish
manifest vascular, neuronal, and functional attributes of DR.
The possibility to apply noninvasive visualization of the
retina and vasculature,57 in combination with in vivo vision
assessment,43,58 will enable correlation of pathophysiology
and progression of both vascular and retinal phenotypes.
Our long-duration DR model offers the opportunity to study
injury responses downstream of pathologic metabolic stress
in the retina, which can reveal new targets for therapeutic
modulation.
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